One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
Aims+Scope/Editorial Board/ Publication information
doi : 10.1016/S0167-8140(25)00151-3
Volume 206, May 2025, 110856
PACE-B: Where does this position SBRT as an option for localized prostate cancer?
Improving performance in radiation oncology: An international systematic review of quality improvement interventions
Rationale, implementation considerations, delineation and planning target objective recommendations for volumetric modulated arc therapy and helical tomotherapy total body irradiation, total marrow irradiation, total marrow and lymphoid irradiation and total lymphoid irradiation
Adaptable framework for cost-analyses in radiotherapy: Application to the cost of proton versus photon therapy for lung cancer in The Netherlands
Impact of bra application in breast cancer radiotherapy: A pilot prospective randomized trial
Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial
Dosimetric predictors of toxicity for brainstem metastases and AVMs treated with stereotactic radiosurgery: An international, multi-institutional analysis
Elective clinical target volume in early squamous cell anal canal cancer: A systematic review and meta-analysis of the risk of recurrence in untreated upper pelvic and external iliac lymph nodes
Multi-contrast 4DMR via MR multitasking: Early clinical experience and implication for liver stereotactic body radiation therapy
Clinical feasibility of treatment planning on a diagnostic CT scan without or with single fraction plan adaptation in patients with stage II/III rectal cancer
Consensus for a postoperative atlas of sinonasal substructures from a modified Delphi study to guide radiotherapy in sinonasal malignancies
Severity of internal lymphedema in unilateral or bilateral radiotherapy patients: An exploratory study
Opioid therapy vs. Multimodal analgesia in head and neck cancer (OPTIMAL-HN): Results of a randomized clinical trial
Neoadjuvant chemoradiotherapy plus sequential tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): A single-arm, bicentric, phase 2 trial
Association between dose to cardiac structures and overall survival: A multivariable analysis in a large, multi-institutional database of stage III NSCLC patients with external validation
Incorporating indirect MRI information in a CT-based deep learning model for prostate auto-segmentation
Radiotherapy quality assurance for the PEACE 1 trial: An individual case review analysis
Response evaluation and tumor shrinkage pattern post-SBRT for renal cell carcinoma
Predicting 30-day mortality with routine blood tests in patients undergoing palliative radiation therapy: A comparison of logistic regression and gradient boosting models
An ultra-high dose rate Bragg peak tracking technique provides more affordable proton radiotherapy for cancer patients: From principle to experimental validation
‘iCycle-pBAO’: Automated patient-specific beam-angle selection in proton therapy applied to oropharyngeal cancer
Dosimetric evaluation of variation in Library of plans selection for cervical cancer radiotherapy
The fractionation effect on proton RBE in a late normal tissue damage model in vivo
PIM kinase inhibition counters resistance to radiotherapy and chemotherapy in human prostate cancer
Low-dose radiation as a potential strategy for alleviating lung injury caused by radiotherapy combined with immunotherapy: A preclinical study
Effect of glioblastoma and brain radiotherapy on T-lymphocyte subpopulations in rodents
Delphi consensus-based recommendations of tools and outcomes for the assessment of radiation dermatitis severity
Response to ‘Pioneering BNCT: Refining strategies for complex cutaneous malignancies
Proton FLASH-Arc therapy: Bridging feasibility to clinical Utility
In response to Yu and Chen: Proton FLASH-Arc Therapy: Bridging feasibility to clinical utility
Comment on Wu et al’s article on toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer
Response to: Comment on Wu et al’s article on toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer
Commentary on feliciani Giacomo et al.’s study of comparison of HDR-brachytherapy and tomotherapy for the treatment of non-melanoma skin cancers of the head and neck
Novel approaches to fiducial-guided SBRT for ultra-central thoracic oligometastases
When predictions don’t match reality: Revisiting sample size and PFS in the OpRAH study
Response to “When predictions don’t match reality: Revisiting sample size and PFS in the OpRAH Study�
Corrigendum to “GEC-ESTRO ACROP prostate brachytherapy guidelines� [Radiother Oncol. 2022; 167: 244–251]
